These findings suggest that the SIRT1-Notch1 signaling axis is important in breast cancer progression, and SIRT1 may be a more important prognostic biomarker in Notch1-depndent manner to breast carcinoma. This evidence concerns the gene NOTCH1 and breast carcinoma.